Edwards Lifesciences acquires JenaValve

Edwards Lifesciences agreed to acquire JenaValve. Reported deal value: $945M. Status: Blocked. Sector: Medical Devices. Target headquarters context: Irvine, California, United States.

This page summarizes publicly available information about the transaction as of 2026-01-12. Figures and status may change as filings and press coverage update.

Print Edwards Lifesciences employs over 5,000 people locally, the most of any medical device maker Edwards Lifesciences Corp . is no longer acquiring structural heart company JenaValve Technology for $945 million after a U.S. District Court granted the Federal Trade Commission motion for an injunction blocking the deal